The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
Abstract
BACKGROUND: Baveno-VI guidelines recommend that patients with compensated cirrhosis with liver stiffness by transient elastography (LSM-TE) <20 kPa and platelets >150,000/mm 3 do not need an esophagogastroduodenoscopy (EGD) to screen for varices, since the risk of having varices needing treatment (VNT) is <5%. It remains uncertain if this tool can be used in patients with cholestatic liver diseases (ChLDs): primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). These patients may have a pre-sinusoidal component of portal hypertension that could affect the performance of this rule. In this study we evaluated the performance of Baveno-VI, expanded Baveno-VI (LSM-TE <25 kPa and platelets >110,000/mm 3 ), and other criteria in predicting the absence of VNT. METHODS: This was a multicenter cross-sectional study in four referral hospitals. We retrospectively analyzed data from 227 patients with compensated advanced chronic liver disease (cACLD) due to PBC ( n = 147) and PSC ( n = 80) that had paired EGD and LSM-TE. We calculated false negative rate (FNR) and number of saved endoscopies for each prediction rule. RESULTS: Prevalence of VNT was 13%. Baveno-VI criteria had a 0% FNR in PBC and PSC, saving 39 and 30% of EGDs, respectively. In PBC the other LSM-TE-based criteria resulted in FNRs >5%. In PSC the expanded Baveno criteria had an adequate performance. In both conditions LSM-TE-independent criteria resulted in an acceptable FNR but saved less EGDs. CONCLUSIONS: Baveno-VI criteria can be applied in patients with cACLD due to ChLDs, which would result in saving 30–40% of EGDs. Expanded criteria in PBC would lead to FNRs >5%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study 90 has demonstrated that patients with compensated cirrhosis in whom NSBBs are not indicated (contraindication/ intolerance) for the prevention of decompensation should undergo an endoscopy for variceal screening if LSM by VCTE is > -20 kPa or platelet count is < -150x10 9 L.”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [90]
In the citing paper
“Applying these criteria in 80 people with PSC-related compensated advanced chronic liver disease, 30% of endoscopies could be saved with an associated risk of missing varices needing treatment of <5%.90”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [90]
Citations
Cites
Expanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
de Franchis, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.004 · Cited by 2,281
Garcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
Self-citationHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Determination of reliability criteria for liver stiffness evaluation by transient elastography
Boursier, J., Zarski, J.-P., de Ledinghen, V., Rousselet, M.-C., Sturm, N., Lebail, B., Fouchard-Hubert, I., Gallois, Y., Oberti, F., Bertrais, S., et al. (2013) · Hepatology · doi:10.1002/hep.25993 · Cited by 662
Steyerberg, E. W., Eijkemans, M. J. C., Harrell, F. E., & Habbema, J. D. F. (2001) · Medical Decision Making · doi:10.1177/0272989x0102100106 · Cited by 550
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
D'Amico, G., Pasta, L., Morabito, A., D'Amico, M., Caltagirone, M., Malizia, G., Tinè, F., Giannuoli, G., Traina, M., Vizzini, G., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12721 · Cited by 547
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC
Corpechot, C., El Naggar, A., Poujol-Robert, A., Ziol, M., Wendum, D., Chazouillères, O., de Lédinghen, V., Dhumeaux, D., Marcellin, P., Beaugrand, M., et al. (2006) · Hepatology · doi:10.1002/hep.21151 · Cited by 441
Abraldes, J. G., Bureau, C., Stefanescu, H., Augustin, S., Ney, M., Blasco, H., Procopet, B., Bosch, J., Genesca, J., Berzigotti, A., et al. (2016) · Hepatology · doi:10.1002/hep.28824 · Cited by 386
Self-citation
Cited by
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Reiberger, T. (2021) · Hepatology Communications · doi:10.1002/hep4.1855 · Cited by 158
You, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
“One study showed that this strategy could avoid 39% of screening EGD with a false negative rate of 0% [170].”
BackgroundCorpechot, C., Carrat, F., Gaouar, F., Chau, F., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Schramm, C., Pares, A., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.017 · Cited by 128
Self-citation
Metadata
- Authors
- Moctezuma-Velazquez, C., Saffioti, F., Tasayco-Huaman, S., Casu, S., Mason, A., Roccarina, D., Vargas, V., Nilsson, J.-E., Tsochatzis, E., Augustin, S., Montano-Loza, A. J., Berzigotti, A., Thorburn, D., Genesca, J., & Abraldes, J. G.
- Affiliations
- Liver Unit, Division of Gastroenterology, CEGIIR, University of Alberta, Edmonton, Canada;
- University of Messina (IT)
- Liver Unit, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Research (VHIR), Universitat Autonoma de Barcelona, Barcelona, Spain;
- University Hospital of Bern (CH)
- University of Alberta (CA)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- American Journal of Gastroenterology
- Published
- 2018-10-12
- Volume
- 114
- Issue
- 3
- Pages
- 446-452
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W2897217492
- Cited by
- 78
- References
- 27
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 6 · 2023: 8 · 2022: 13 · 2021: 18 · 2020: 10 · 2019: 16
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- variceal bleeding, primary biliary cirrhosis, primary sclerosing cholangitis, cholestatic liver disease, Baveno VI criteria, transient elastography, liver stiffness, portal hypertension, upper gastrointestinal endoscopy, variceal screening, false negative rate, non-invasive prediction
- MeSH terms
- Adult, Aged, Cross-Sectional Studies, Esophageal and Gastric Varices, False Negative Reactions, Female, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis, Biliary, Male, Middle Aged, Platelet Count, Retrospective Studies, Cholangitis, Sclerosing, Prevalence, Endoscopy, Digestive System, Risk Assessment, Elasticity Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.1038/s41395-018-0265-7
- The paper
- Moctezuma-Velazquez, C., Saffioti, F., Tasayco-Huaman, S., Casu, S., Mason, A., Roccarina, D., Vargas, V., Nilsson, J.-E., Tsochatzis, E., Augustin, S., Montano-Loza, A. J., Berzigotti, A., Thorburn, D., Genesca, J., & Abraldes, J. G. (2019). Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. American Journal of Gastroenterology. https://doi.org/10.1038/s41395-018-0265-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.